Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Alpha Cognition Inc. (ACOG : NSDQ)

• Company Description    Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia. Number of Employees: 57

• Price / Volume Information    Yesterday's Closing Price: $5.31 Daily Weekly Monthly 20 Day Moving Average: 78,520 shares Shares Outstanding: 21.74 (millions) Market Capitalization: $115.45 (millions) Beta: 2.62 52 Week High: $11.54 52 Week Low: $3.75 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -13.38% -14.52% 12 Week -38.11% -39.88% Year To Date -9.85% -15.64%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1452 Hughes Rd. Ste. 200 - Grapevine,TX 76051 CAN ph: 858-344-4375 fax: - ir@alphacognition.com http://www.alphacognition.com

• General Corporate Information    Officers Michael McFadden - Chief Executive Officer Henry Du - Chief Financial Officer; Vice President of Finance Len Mertz - Director Kenneth Cawkell - Director John Havens - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 02074J501 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/30/26 Share - Related Items Shares Outstanding: 21.74 Most Recent Split Date: 11.00 (0.04:1) Beta: 2.62 Market Capitalization: $115.45 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.25 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.06 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/30/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.27 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 3.23% vs. Previous Quarter: 53.85% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: 71.35% ROE 09/30/25 - -62.82 06/30/25 - -80.16 03/31/25 - -65.83 ROA 09/30/25 - -50.12 06/30/25 - -60.95 03/31/25 - -48.21 Current Ratio 09/30/25 - 6.69 06/30/25 - - 03/31/25 - 17.14 Quick Ratio 09/30/25 - 6.03 06/30/25 - - 03/31/25 - 16.83 Operating Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Net Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Pre-Tax Margin 09/30/25 - - 06/30/25 - - 03/31/25 - -397.44 Book Value 09/30/25 - 1.62 06/30/25 - - 03/31/25 - 2.55 Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - 2.23 Debt-to-Equity 09/30/25 - 0.00 06/30/25 - - 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - 0.00 06/30/25 - - 03/31/25 - 0.00

Powered by Zacks Investment Research ©